Antineoplastic Drugs And Targeted Therapies Flashcards
Alopecia
Abnormal loss of hair, baldness
Anemia
Decrease in the number of red blood cells and hemoglobin value below normal
Antineoplastic
Drug used to treat neoplasia (cancer)
Bone marrow suppression
Decreased production of all blood cells aka meylosuppression
Cell cycle nonspecific
Pertaining to a drug used in cancer treatment, effective in any phase of cell division
Cell cycle specific
Pertaining to a drug used in cancer treatment, affecting a specific phase of cell division
Chemotherapy
Drug therapy with a chemical, often used when referring to treatment with an antineoplastic drug
Metastasis
Spread of cancer outside the original organ or tissue
Neoplasm
A group of cells that undergo an abnormal growth pattern
Neutropenia
Abnormally low number of neutrophils (infection fighting type of white blood cell)
Oncogenes
A genre, which can make a cell become cancerous with specific circumstances
Oral mucositis
Inflammation of the oral mucous membranes
Palliation
Therapy designed to treat symptoms, not to produce a cure
Tumor suppressor genes
A gene, which protects a cell from becoming cancerous
Vesicant
Caustic drug substance
Phase 1 of cell growth
G1 phase: RNA and proteins are built
Phase 2 of cell growth
Phase S: DNA is made from the components of the G1 phase
Phase 3 of cell growth
Phase
G2: RNA and protein synthesis preparing for cell division
Phase 4 of cell growth
Phase M: mitotic cell division (cell has doubles its contents and splits into 2 separate cells)
Phase 5 of cell growth
Phase G0: the dormant or resting phase (cell starts performing its usual function in the body or prepares to start cell division process again)
Fractional kill cell hypothesis
1st chemo treatment will kill 90% of cells, and then this process continues until there is so few cancer cells left, that the immune system takes over and no cancer remains (hypothetically)
Cell cycle specific drugs use
Affect both malignant and normal cells, used to treat leukemias, lymohomas, and a variety of solid tumors
vinca alkaloids MOA
Interfere with amino acid production in the S phase and formation of microtubules in the M phase
taxanes MOA
Interfere in the M phase with microtubukes
Podophyllotoxins MOA
Cells are stopped in the S and G2 phases and are unable to divide
Camptothecin analogs MOA
DNA synthesis during the S phase is inhibited
Antimetabolites use
Many leukemias, lymohomas, and solid tumors and autoimmune diseases
Antimetabolites MOA
Interfere with the synthesis of DNA and RNA In The S phase, making it impossible for both cells to divide
Cell cycle nonspecific Drugs use
To cure, control, or provide palliation for leukemias, lymohomas, and solid tumors and autoimmune diseases
Alkylating agents
Make the cell a more alkaline environment, which damages the cell
Alkylating agents effects considerations
Malignancy cells are more susceptible to the effects rather than normal cells
Nitrogen mustard derivatives MOA
Break or interfere with the cross links in DNA structure
Ethyleneimines MOA
Break or interfere with the cross links in DNA structures
Platinum based drugs MOA
Interfere and real the cross links in DNA structures
Busulfan MOA
Interferes with granulocyte DNA
Busulfan use
Leukemia
Hydrazine group MOA
Interferes with multiple phases in the synthesis of RNA, DNA and protein
Nitrosureas use
Brain tumors because they can cross the blood brain barrier
Antineoplastic antibiotics MOA
Intercederé with DNA and RNA synthesis, delaying or inhibiting cell divisor and blocking the reproductive ability of malignant cells
Doxorubicin use
Solid tumors
Antineoplastics immediate side effects
Nausea, vomiting, IV extravasation of irritating solutions,
Alkylating agents that have a high chance of causing nausea and vomiting
Carboplatin, carmustine, cisplatin, cyclophosphamide, dacarbazine, ifosfamide, lomustine, mechlorethamine, melphalan, procarbazine, streptozocin
Antineoplastic antibiotics that are likely to cause nausea and vomiting
Dactinomycin, daunorubicin, doxorubicin, mitoxantrone
Antimetabolites likely to cause nausea and vomiting
Cytarabine, methotrexate
Plant alkaloids likely to cause nausea and vomiting
Irinotecan
Common antineoplastic side effects
Bone marrow suppression, stomatitis , diarrhea, hair loss, leukopenia, thrombocytopenia (can delay cycles of chemo until blood cell counts can be raised again)
antineoplastic Alkaloids side effects
Peripheral tingling sensation, hand and foot syndrome (tiny capillary leaks in extremities, causing skin color changes and numbness), and many other CNS reactions
Antineoplastic long term side effects
Damage to the gonads, causing fertility problems, and can lead to cardia, pulmonary, neurological problems and even secondary cancers
Antineoplastic contraindications
Leukopenia, thrombocytopenia, anemia, steroid infections, seroius renal disease, pregnancy
Antineoplastics precautions
Renal or hepatic impairment, active infection, other debilitated illness, or in people who have recently completed treatment with other antineoplastics or radiation therapy
Pregnancy cat C antineoplastics
Aspariginase, dacarbazine, mitotane, pegaspargase, streptozocin,
Pregnancy cat D antineoplastics
Altretamine, azacitidine, bleomycin, busulfan, cabazitaxel, capecitabine, carboplatin, carmustine, chlorambucil, cisplastin, cladribine, clofarabine, cyclophosphamide, cytarabine, dactinomycin, daunorubicin + many many more
Pregnancy cat X antineoplastic
Methotrexate, thaliamide
Cytoprotective agents
Used with antineoplastics to protect normal cells or organs of the body
Cytoprotective agents ex
Allopurinol and rasburicase (stop uric acid increase and hyperuricemia) amifostine (protect kidneys), dexrazoxane (cardioprotective), famotidine (reduce hypersensitivity), lecuvorin and glucarpidase (provide folic acid), levoleucovorin (rescue for high dose methotrexate), mesna (protect bladder), palifermin (help cells in oral cavity recover)
Plant alkaloids interactions
Increased serum levels of digoxin, phenytoin increases seizure risk, oral anticoagulants prolong bleeding
Antimetabolites interactions
Decreased serum level of digoxin, phenytoin decreases need for anti seizure meds, NSAIDs increase risk of methotrexate toxicity
Alkylating drugs interactions
Aminoglycosides increase risk of nephrotoxicity and ototoxicity, loop diuretics increase risk of ototoxicity, and phenytoin increases risk of seizures
Antineoplastic antibiotics interactions
Decreased serum levels of digoxin
Antineoplastics misc interactions
Insulin and oral antidiabetics increase risk of hyperglycemia, oral anticoagulants prolong bleeding, antidepressants, antihistamines, opiates and sedatives increase risk of CNS depression
Human epidermal growth factor receptor 2(HER-2) MOA
Higher amount of protein in cancer cell becomes a target for HER-2 in breast cancer
Vemurafenib MOA
Mutated protein in melanoma is the target of this
Imatinib MOA
in some leukemia cells, 2 different genes can fuse together, becoming the target for this
Targeted therapy Sid effects nature
Less side effects than chemo because they leave healthy cells alone
Targeted therapy side effects
Acne rash, dry skin,nail changes, hair depigmentation, photosensitivity, thinning, brittle, yellowish dry hair, increased facial hair, diarrhea, hepatitis, elevated liver enzymes, hand and foot syndrome, angioedema, delayed blood clotting and wound healing, high blood pressure or cardiac damage
Targeted therapy for adenocarcinoma of the stomach ex
Trastuzumab, ramucirumab
Targeted therapy for basal cell carcinoma ex
Vismodegib, sonidegib
Targeted therapy for bladder cancer ex
Atezolizumab
Targeted therapy for brain cancer ex
Bevacizumab, everolimus
Targeted therapy for breast cancer ex
Everolimus, tamoxifen, toremifene, tratazumab, fulvestrant, anastrozole, exemestane, lapatinib, letrozole, pertuzumab, ado-trastuzumab emtansine, palbociclib
Cervical cancer targeted therapy ex
Bevacizumab
Colorectal cancer targeted therapies ex
Cetuximab, panitumumab, bevacizumab, ziv-alfibercept, regorafenib, ramucirumab
Endocrine/neuroendocrine tumors targeted therapy ex
Lanreotide
Head and neck cancer targeted therapies
Cetuximab, pembrolizumab, nivolumab
Gastrointestinal storm al tumor (GIST) targeted therapies ex
Imatinib, sunitinib, regorafenib
Kaposi sarcoms targeted therapies ex
Alitretinoin
Kidney cancer targeted therapies ex
Bevacizumab, sorafenib, sunitinib, pazobanib, temsirolimus, everolimus, axitinib, nivolumab, cabozantinib, levantinib
Leukemia targeted therapies ex
Tretinoin, imatinib, dasatinib, nilotinib, bosutinib, rituximab, alemtuzumab, ofatumumab, obinutuzumab, omacetaxine, ibrutinib, idelalisib, blinatuminab, venetoclax
Liver cancer targeted therapy ex
Sorafenib
Lung cancer targeted therapy ex
Bevacizumab, crizotinib, erlotinib, gefitinib, afatinib, ceritinib, ramucirumab, nivolumab, pembrolizumab, osimertinib, necitumumab, alectinib, atezolizumab
Lymohomas targeted therapies ex
Ibritumomab tiuxetan, denileukin diftitox, brentuximab vedotin, rituximab, vorinostat, romidepsin, bexarotene, bortezomib, pralatrexate, ibrutinib, siltuximab, idelalisib, belinostat, obinutuzumab, nivolumab
Melanoma targeted therapy ex
Ipilimumab, vemurafenib, trametinib, dabrafenib, pembrolizumab, nivolumab, cobimetinib
Multiple myeloma targeted therapy ex
Bortezomib, carfilzomib, panobinostat, daratumumab, ixazomib, elotuzumab, lenalidomide, pomalidomide, thalidomide (last 3 cause extreme birth defects and are administered under strict protocol)
Myelodyplastic/myeloproliferative disorders targeted therapies ex
Imatinib, ruxolitinib
Neuroblastoma targeted therapies ex
Dinutuximab
Ovarian and female GU cancers targeted therapies ex
Bevacizumab, olaparib
Pancreatic cancer targeted therapies ex
Erlotinib, everolimus, sunitinib,
Prostate cancer targeted therapies ex
Cabazitaxel, enzalutamide, abiraterone, radium 223 dichloride
Soft tissue sarcoma targeted therapies ex
Pazopanib, olaratumab
Thyroid cancer targeted therapy ex
Cabozantinib, vandetanib, sorafenib, lenvatinib
Signs of improvement with erlotinib
Acne-like rash occurs
Signs of improvement with gefitinib
Acne-like rash
Signs of improvement with bevacizumab
Increased blood pressure
Targeted therapies interactions
May interfere with oral contraceptives, oral antidiabetics increase blood glucose levels, and increased bleeding can occur with anticoagulants
Targeted therapies precautions
Children, immunosuppression and reduced sperm count can occur
Vismodegib contraindications
Don’t give blood for a year after treatment
Sonidegib contraindications
Don’t give blood for 1 year after treatment
Antineoplastic pregnancy considerations
Pregnancy nurses shouldn’t handle these drugs
Temozolomide side effects
Very severe leukopenia in conjunction with radiation to the brain, patients should be started on prophylactic therapy to prevent pneumocystis pneumonia (PCP)
Who is at the greatest risk for extravastation
Elderly, debilitated, confused, and patients with fragile veins
Vinca alkaloids ex
Vinblastine, vincristine, vinorelbine
Taxanes ex
Cabazitaxel, docetaxel, paclitaxel,
Podophyllotoxins ex
Etoposide, teniposide
Camptothecin analogs ex
Irinotecan, topotecan
Antimetabolites ex
Azacitidine, capecitabine, cladribine, clofarabine, cytarabine, decitabine, fludarabine, fluorouracil, gemcitabine, mercaptopurine, methotrexate, nelarbine, pemetrexed, pentostatin, pralatrexate, trifluridine, thioguanine
Misc cell cycle specific drugs ex
Ixabepilone
Nitrogen mustard derivatives ex
Chlorambucil, cyclophosphamide, ifosfamide, mechlorethamine, melphalan
Ethyleneimines ex
Altretamine, bendamustine, thiotepa
Alkyl sulfonate ex
Busulfan
Hydrazine ex
Dacarbazine, procarbazine, temozolomide,
Nitrosoureas ex
Carmustine, lomustine, streptozocin
Platinum based drugs ex
Cisplatin, oxaliplatin, carboplatin,
Antineoplastic antibiotics ex
Bleomycin, dactinomycin, daunorubicin, doxorubicin, epirubicin, idarubicin, mitomycin, mitoxantrone
DNA inhibitor ex
Hydroxyurea
Adrenocortical inhibitor ex
Mitotane
Antineoplastic enzymes ex
Asparaginase, pegaspargase
Antimicrotubule agents ex
Estramustine
Retinoids ex
Tretinoin, bexarotene